ImageneBio Inc

ImageneBio Incverified

IMA

Price:

$6.78

Market Cap:

$75.81M

Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis

Industry

Biotechnology

IPO Date

1998-02-27

Stock Exchange

NASDAQ

Ticker

IMA

The ROE as of December 2025 (TTM) for ImageneBio Inc (IMA) is -24.88%

According to ImageneBio Inc’s latest financial reports and current stock price. The company's current ROE is -24.88%. This represents a change of 305.42% compared to the average of -6.14% of the last 4 quarters.

ImageneBio Inc (IMA) Historical ROE (quarterly & annually)

How has IMA ROE performed in the past?

The mean historical ROE of ImageneBio Inc over the last ten years is -15.16%. The current -24.88% ROE has changed 64.08% with respect to the historical average. Over the past ten years (40 quarters), IMA's ROE was at its highest in in the December 2020 quarter at 25.78%. The ROE was at its lowest in in the September 2020 quarter at -1695.37%.

Quarterly (TTM)
Annual

Average

-15.16%

Median

-39.10%

Minimum

-96.63%

Maximum

89.15%

ImageneBio Inc (IMA) ROE by Quarter and Year

Discovering the peaks and valleys of ImageneBio Inc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 185.10%

Maximum Annual ROE = 89.15%

Minimum Annual Increase = -208.39%

Minimum Annual ROE = -96.63%

Quarterly (TTM)
Annual
YearROEChange
2024-39.10%-2.64%
2023-40.16%-14.18%
2022-46.79%185.10%
2021-16.41%-137.47%
202043.80%-145.33%
2019-96.63%-208.39%

ImageneBio Inc (IMA) Average ROE

How has IMA ROE performed in the past?

The current ROE of ImageneBio Inc (IMA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-42.01%

5-year avg

-19.73%

10-year avg

-15.16%

ImageneBio Inc (IMA) ROE vs. Peers

How is IMA’s ROE compared to its peers?

ImageneBio Inc’s ROE is greater than Connect Biopharma Holdings Limited (-44.18%), greater than InflaRx N.V. (-71.27%), greater than Kalaris Therapeutics Inc (-76.00%), greater than Shattuck Labs, Inc. (-73.82%), greater than Context Therapeutics Inc. (-38.80%), less than Sutro Biopharma, Inc. (861.99%), greater than Artiva Biotherapeutics, Inc. (-45.64%), greater than Ovid Therapeutics Inc. (-63.74%), greater than Metagenomi, Inc. Common Stock (-38.76%), greater than Quince Therapeutics, Inc. (-186.08%),

Build a custom stock screener for ImageneBio Inc (IMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImageneBio Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImageneBio Inc (IMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImageneBio Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is ImageneBio Inc's ROE?

How is the ROE calculated for ImageneBio Inc (IMA)?

What is the highest ROE for ImageneBio Inc (IMA)?

What is the 3-year average ROE for ImageneBio Inc (IMA)?

What is the 5-year average ROE for ImageneBio Inc (IMA)?

How does the current ROE for ImageneBio Inc (IMA) compare to its historical average?